NCT00092885View on ClinicalTrials.gov

An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269)

PHASE3CompletedINTERVENTIONAL

Enrollment

831

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

October 31, 2003

Study Completion Date

October 31, 2003

Conditions

Rhinitis, Allergic, SeasonalAsthma, Bronchial

Interventions

DRUG

MK0476, montelukast sodium

DRUG

Comparator: placebo

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00092885 - An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269) | Biotech Hunter | Biotech Hunter